Literature DB >> 7590877

In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

S H Zuckerman1, N Bryan-Poole, G F Evans, L Short, A L Glasebrook.   

Abstract

Oestrogen has been reported to modulate tumour necrosis factor (TNF), interleukin (IL)-1 and IL-6 cytokine levels in human mononuclear cell cultures. In the present study, the effects of exogenous oestrogen administration on the cytokine response to an endotoxin challenge was investigated in a murine model of endotoxemia. Animals pretreated for 4 days with 17 alpha ethinyl oestradiol exhibited divergent regulation of TNF and IL-6 levels in sera from endotoxin-stimulated mice. Oestrogen treatment resulted in a significant increase in serum TNF while serum IL-6 levels, relative to the placebo group, decreased in response to an endotoxin challenge. These oestrogenic effects were dose dependent with maximal elevations observed in TNF at 1 mg/kg and maximal reduction in IL-6 at 0.1 mg/kg of 17 alpha ethinyl oestradiol. The increase in TNF levels by ethinyl oestradiol was blocked by co-administration of the oestrogen receptor antagonist tamoxifen. Oestrogen-mediated modulation of the TNF and IL-6 response to endotoxin was also apparent in animals implanted with 17 beta oestradiol pellets. The oestrogen-mediated effects on serum IL-6 were consistent with a reduction in IL-6 mRNA in peritoneal macrophages from oestrogen-treated mice. The effects of oestrogen on TNF and IL-6 production were also investigated in vitro. Oestradiol-treated macrophage cultures produced three- to fourfold lower amounts of IL-6 without any significant modulatory effects on TNF secretion. The combined in vivo and in vitro results demonstrate the modulation of IL-6 and TNF during endotoxemia by oestrogen analogues through an oestrogen receptor-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590877      PMCID: PMC1383805     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study.

Authors: 
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

2.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

3.  Approach to the study of the role of sex hormones in autoimmunity.

Authors:  A D Steinberg; K A Melez; E S Raveche; J P Reeves; W A Boegel; P A Smathers; J D Taurog; L Weinlein; M Duvic
Journal:  Arthritis Rheum       Date:  1979-11

4.  Effect of pregnancy on the prognosis and serology of rheumatoid arthritis.

Authors:  M Oka; U Vainio
Journal:  Acta Rheumatol Scand       Date:  1966

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect.

Authors:  J P Vandenbroucke; H A Valkenburg; J W Boersma; A Cats; J J Festen; O Huber-Bruning; J J Rasker
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

7.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes.

Authors:  D Friedman; F Netti; A D Schreiber
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

Authors:  C Christiansen; M S Christensen; N E Larsen; I B Transbøl
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

10.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  18 in total

1.  Gender influences the response to experimental silica-induced lung fibrosis in mice.

Authors:  David M Brass; Sean P McGee; Mary K Dunkel; Sarah M Reilly; Jacob M Tobolewski; Tara Sabo-Attwood; Cheryl L Fattman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

Authors:  S C Lin; T Yamate; Y Taguchi; V Z Borba; G Girasole; C A O'Brien; T Bellido; E Abe; S C Manolagas
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 4.  Sex hormones and modulation of immunity against leishmaniasis.

Authors:  Heidi Snider; Claudio Lezama-Davila; James Alexander; Abhay R Satoskar
Journal:  Neuroimmunomodulation       Date:  2009-02-11       Impact factor: 2.492

5.  Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality.

Authors:  Milap V Rakholia; Raj G Kumar; Byung-Mo Oh; Prerna R Ranganathan; Sarah L Berga; Patrick M Kochanek; Amy K Wagner
Journal:  J Neurotrauma       Date:  2018-08-24       Impact factor: 5.269

6.  Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.

Authors:  Claudine Guilbault; Peter Stotland; Claude Lachance; Mifong Tam; Anna Keller; Luann Thompson-Snipes; Elizabeth Cowley; Thomas A Hamilton; David H Eidelman; Mary M Stevenson; Danuta Radzioch
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

7.  Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia.

Authors:  S H Zuckerman; S E Ahmari; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

8.  T lymphocytes are not the target for estradiol-mediated suppression of DTH in reconstituted female severe combined immunodeficient (SCID) mice.

Authors:  M Taube; L Svensson; H Carlsten
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Effect of oophorectomy and exogenous estrogen replacement on liver injury in experimental obstructive jaundice.

Authors:  Hamdi Bulent Ucan; Mehmet Kaplan; Bulent Salman; Utku Yilmaz; B-Bulent Mentes; Cemalettin Aybay
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 10.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.